Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study

Keywords: Allergic Rhinitis, Treatment Adherence, Mobile Health, Clinical Guidelines, Patient-Centered Care, Research Study, Asthma, Medication Patterns, Visual Analog Scales, Health Technology   Summary:  In this podcast episode, Mo Shamji interviews Bernardo Sousa Pinto about his recent study on treatment adherence in allergic rhinitis during the pollen season in Europe. The discussion covers the rationale behind the study, the use of mobile health apps for data collection, unexpected findings regarding medication adherence, and the implications for future clinical guidelines. The conversation emphasizes the importance of understanding patient behavior and tailoring recommendations to improve treatment outcomes.   Takeaways The study focuses on adherence to treatment in allergic rhinitis. Patients often do not adhere to their medication regimens. Mobile health apps can provide valuable data on patient behavior. Adherence patterns vary by medication type. Unexpectedly, partially adherent patients had better symptom control with fixed combinations. The findings may influence future guidelines for allergic rhinitis treatment. A patient-centered approach is essential in developing recommendations. Observational data can inform clinical practice despite limitations. Future studies should explore intervention strategies for non-adherent patients. The integration of mobile health data can enhance understanding of treatment adherence. Titles Exploring Treatment Adherence in Allergic Rhinitis The Role of Mobile Health in Allergy Management   Chapters 00:00 Introduction to the Podcast and Guest 02:31 Understanding the Study's Rationale and Hypotheses 04:58 Exploring the MassCare App and Its Methodology 07:35 Unexpected Findings and Their Implications 10:29 Impact on Future Guidelines and Research Directions

Om Podcasten

Summary This conversation highlights the significant contributions of the Clinical and Experimental Allergy (CEA) journal to the field of allergy research and clinical practice. The hosts and Editors-In-Chief discuss the journal’s achievements, including advancements in allergy diagnosis, innovative treatments, and a focus on patient-centric research. They also outline future directions for the journal, emphasising collaboration and accessibility in allergy research. Takeaways - CEA is a leading publication in allergy and immunology. - The journal publishes groundbreaking research on allergy mechanisms. - Innovative diagnostic methods are a focus of CEA’s contributions. - Promising new treatments, including biologics, are showcased. - Food allergy research informs better management practices. - Environmental factors influencing allergies are examined. - Patient-reported outcomes are prioritised in research. - The journal’s Impact Factor has reached a record high. - Future plans include enhancing author support and engagement. - Collaboration with patient organisations is a key focus for CEA.